Selected Publications
- Kleissl L*, Weninger S*, Winkler F, Ruivo M, Wijnveld M, Strobl J. Ticks' tricks: Immunomodulatory effects of ixodid tick saliva at the cutaneous tick-host interface. Front Immunol. 2025 Mar 27;16:1520665. doi: 10.3389/fimmu.2025.1520665.
- Strobl J, Ballicas N, Wachter B, Revertera M, Knaus H, Wohlfarth P, Rabitsch W, Kuchler U, Hopfinger G. Dental health, conditioning and oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-center study. Cytotherapy. 2025 Mar 28:S1465-3249(25)00090-8. doi: 10.1016/j.jcyt.2025.03.005.
- Li R*, Strobl J*, Poyner EFM*, Balbaa A*, Torabi F, Mazin PV, Chipampe NJ, Stephenson E, Ramírez-Suástegi C, Shanmugiah VBM, Gardner L, Olabi B, Coulthard R, Botting RA, Zila N, Prigmore E, Gopee NH, Chroscik MA, Kritikaki E, Engelbert J, Goh I, Chan HM, Johnson HF, Ellis J, Rowe V, Tun W, Reynolds G, Yang D, Foster AR, Gambardella L, Winheim E, Admane C, Rumney B, Steele L, Jardine L, Nenonen J, Pickard K, Lumley J, Hampton P, Hu S, Liu F, Liu X, Horsfall D, Basurto-Lozada D, Grimble L, Bacon CM, Weatherhead SC, Brauner H, Wang Y, Bai F, Reynolds NJ, Allen JE, Jonak C, Brunner PM, Teichmann SA, Haniffa M. Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment. Nat Immunol. 2024 Dec;25(12):2320-2330. doi: 10.1038/s41590-024-02018-1. Epub 2024 Nov 18. Erratum in: Nat Immunol. 2025 Jan;26(1):147. doi: 10.1038/s41590-024-02046-x.
- Strobl J, Gail LM, Krecu L, Madad S, Kleissl L, Unterluggauer L, Redl A, Brazdilova K, Saluzzo S, Wohlfarth P, Knaus HA, Mitterbauer M, Rabitsch W, Haniffa M, Stary G. Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease. Br J Dermatol. 2024 Feb 16;190(3):402-414. doi: 10.1093/bjd/ljad402. Erratum in: Br J Dermatol. 2024 Jun 20;191(1):e1. doi: 10.1093/bjd/ljae157. PMID: 38010706.
- Strobl J, Haniffa M. Functional heterogeneity of human skin-resident memory T cells in health and disease. Immunol Rev. 2023 Jul;316(1):104-119. doi: 10.1111/imr.13213. Epub 2023 May 5. PMID: 37144705.
- Pandey RV*, Strobl J*, Redl A, Unterluggauer L, Gail L, Kleissl L, Müller S, Atzmüller D, Fife-Gernedl V, Krausgruber T, Knaus H, Mitterbauer M, Wohlfarth P, Rabitsch W, Bock C, Stary G. Epigenetic regulation of T cell lineages in skin and blood following hematopoietic stem cell transplantation. Clin Immunol. 2023 Mar;248:109245. doi: 10.1016/j.clim.2023.109245. Epub 2023 Jan 23. PMID: 36702179.
- Strobl J, Muendler V, Müller S, Gindl A, Berent S, Schötta AM, Kleissl L, Staud C, Redl A, Unterluggauer L, Aguilar González AE, Weninger ST, Atzmüller D, Klasinc R, Stanek G, Markowicz M, Stockinger H, Stary G. Tick feeding modulates the human skin immune landscape to facilitate tick-borne pathogen transmission. J Clin Invest. 2022 Sep 27:e161188. doi: 10.1172/JCI161188.
- Strobl J*, Patra V*, Atzmüller D, Reininger B, Kleissl L, Gruber-Wackernagel A, Nicolas JF, Stary G, Vocanson M, Wolf P. Accumulation of Cytotoxic Skin Resident Memory T Cells and Increased Expression of IL-15 in Lesional Skin of Polymorphic Light Eruption. Front Med (Lausanne). 2022 Jun 10;9:908047. doi: 10.3389/fmed.2022.908047.
- Gindl A, Schötta AM, Berent S, Markowicz M, Stockinger H, Thalhammer F, Stary G*, Strobl J*. Persistent Lyme disease with cutaneous Borrelia biofilm formation. Br J Dermatol. 2022 Jun;186(6):1041-1043. doi: 10.1111/bjd.20977. Epub 2022 Apr 3.
- Strobl J*, Gail LM*, Kleissl L, Pandey RV, Smejkal V, Huber J, Puxkandl V, Unterluggauer L, Dingelmaier-Hovorka R, Atzmüller D, Krausgruber T, Bock C, Wohlfarth P, Rabitsch W, Stary G. Human resident memory T cells exit the skin and mediate systemic Th2-driven inflammation. J Exp Med. 2021 Nov 1;218(11):e20210417. doi: 10.1084/jem.20210417.
- Strobl J, Pandey RV, Krausgruber T, Bayer N, Kleissl L, Reininger B, Vieyra-Garcia P, Wolf P, Jentus MM, Mitterbauer M, Wohlfarth P, Rabitsch W, Stingl G, Bock C, Stary G. Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease. Sci Transl Med. 2020 Nov 18;12(570):eabb7028. doi: 10.1126/scitranslmed.abb7028.
- Strobl J, Pandey RV, Krausgruber T, Kleissl L, Reininger B, Herac M, Bayer N, Krall C, Wohlfarth P, Mitterbauer M, Kalhs P, Rabitsch W, Bock C, Hopfinger G, Stary G. Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease. J Invest Dermatol. 2020 Nov;140(11):2188-2198. doi: 10.1016/j.jid.2020.02.029.